Nido Biosciences Funding: $109M Raised, Series B (2023)

Nido Biosciences funding overview

Nido Biosciences is based in Boston. Nido Biosciences has raised $109M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2023. The round record for Nido Biosciences runs through 2023; nothing later has been disclosed. Investors on record include Bioluminescence Ventures, Eli Lilly, Bessemer Venture Partners, 5AM Ventures, Abingworth, Osage University Partners. 6 distinct backers are named across the disclosed rounds.

Nido Biosciences at a glance

Total raised: $109M
Latest round: Series B
Latest round date: May 2023
Headquarters: Boston
Notable investors: Bioluminescence Ventures, Eli Lilly, Bessemer Venture Partners, 5AM Ventures, Abingworth, Osage University Partners

Frequently asked about Nido Biosciences funding

How much has Nido Biosciences raised?: Nido Biosciences has raised $109M in total disclosed funding across the rounds on record.
Who has invested in Nido Biosciences?: Bioluminescence Ventures, Eli Lilly, Bessemer Venture Partners, 5AM Ventures, Abingworth, Osage University Partners are named among the investors backing Nido Biosciences.
What was the latest Nido Biosciences funding round?: The most recent disclosed round is a Series B, announced in May 2023.
Where is Nido Biosciences based?: Nido Biosciences is based in Boston.
When did Nido Biosciences last raise?: The last disclosed Nido Biosciences round closed in May 2023 at Series B.

Nido Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.

Nido Biosciences Funding: $109M Raised, Series B (2023)

Nido Biosciences funding overview

Nido Biosciences at a glance

Frequently asked about Nido Biosciences funding

Companies related to Nido Biosciences (21)

Browse related funding lists (10)